Biomarkers of impaired placentation at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
Adult
Biomarkers
/ blood
Cesarean Section
Female
Humans
Hypoxia-Ischemia, Brain
/ epidemiology
Infant, Newborn
Infant, Small for Gestational Age
/ metabolism
Intensive Care Units, Neonatal
/ statistics & numerical data
Perinatal Death
Placenta Growth Factor
/ metabolism
Placentation
Pregnancy
/ metabolism
Pregnancy Outcome
/ epidemiology
Pregnancy Trimester, Third
Prospective Studies
Pulsatile Flow
/ physiology
Stillbirth
/ epidemiology
Ultrasonography, Doppler, Color
/ methods
Uterine Artery
/ diagnostic imaging
Vascular Endothelial Growth Factor Receptor-1
/ metabolism
Cesarean section
hypoxic ischemic encephalopathy
neonatal unit admission
perinatal death
perinatal hypoxia
placental growth factor
small-for-gestational age
soluble fms-like tyrosine kinase-1
stillbirth
third-trimester screening
uterine artery Doppler
Journal
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
ISSN: 1469-0705
Titre abrégé: Ultrasound Obstet Gynecol
Pays: England
ID NLM: 9108340
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
17
04
2019
revised:
13
05
2019
accepted:
13
05
2019
pubmed:
18
5
2019
medline:
28
1
2020
entrez:
18
5
2019
Statut:
ppublish
Résumé
To investigate the potential value of uterine artery pulsatility index (UtA-PI) and serum levels of the angiogenic placental growth factor (PlGF) and the antiangiogenic factor soluble fms-like tyrosine kinase-1 (sFlt-1) in the prediction of adverse perinatal outcome in small-for-gestational-age (SGA) and non-SGA neonates at 35-37 weeks' gestation. This was a prospective observational study of 19 209 singleton pregnancies attending for a routine hospital visit at 35 + 0 to 36 + 6 weeks' gestation. This visit included recording of maternal demographic characteristics and medical history, sonographic estimation of fetal weight, color Doppler ultrasound for measurement of mean UtA-PI, and measurement of serum concentrations of PlGF and sFlt-1. Multivariable logistic regression analysis was carried out to determine which of the factors from maternal or pregnancy characteristics and measurements of UtA-PI, PlGF and sFlt-1 provided a significant contribution in the prediction of each of four adverse outcome measures: first, stillbirth; second, Cesarean delivery for suspected fetal compromise in labor; third, neonatal death or hypoxic ischemic encephalopathy Grade 2 or 3; and, fourth, admission to the neonatal unit (NNU) for ≥ 48 h. Predicted probabilities from logistic regression analysis were used to construct receiver-operating characteristics curves to assess the performance of screening for these adverse outcomes. First, 83% of stillbirths, 82% of Cesarean sections for presumed fetal compromise in labor, 91% of cases of neonatal death or hypoxic ischemic encephalopathy and 86% of NNU admissions for ≥ 48 h occurred in pregnancies with a non-SGA neonate. Second, UtA-PI > 95 In pregnancies undergoing routine antenatal assessment at 35-37 weeks' gestation, measurements of UtA-PI, sFlt-1 or PlGF provide poor prediction of adverse perinatal outcome in both SGA and non-SGA fetuses. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.
Substances chimiques
Biomarkers
0
PGF protein, human
0
Placenta Growth Factor
144589-93-5
FLT1 protein, human
EC 2.7.10.1
Vascular Endothelial Growth Factor Receptor-1
EC 2.7.10.1
Types de publication
Comparative Study
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
79-86Subventions
Organisme : Fetal Medicine Foundation
ID : 1037116
Informations de copyright
Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.